RT Journal Article
SR Electronic
T1 Age profile of susceptibility, mixing, and social distancing shape the dynamics of the novel coronavirus disease 2019 outbreak in China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.19.20039107
DO 10.1101/2020.03.19.20039107
A1 Zhang, Juanjuan
A1 Litvinova, Maria
A1 Liang, Yuxia
A1 Wang, Yan
A1 Wang, Wei
A1 Zhao, Shanlu
A1 Wu, Qianhui
A1 Merler, Stefano
A1 Viboud, Cecile
A1 Vespignani, Alessandro
A1 Ajelli, Marco
A1 Yu, Hongjie
YR 2020
UL http://medrxiv.org/content/early/2020/03/20/2020.03.19.20039107.abstract
AB Strict interventions were successful to control the novel coronavirus (COVID-19) outbreak in China. As transmission intensifies in other countries, the interplay between age, contact patterns, social distancing, susceptibility to infection and disease, and COVID-19 dynamics remains unclear. To answer these questions, we analyze contact surveys data for Wuhan and Shanghai before and during the outbreak and contact tracing information from Hunan Province. Daily contacts were reduced 7-9 fold during the COVID-19 social distancing period, with most interactions restricted to the household. Children 0-14 years were 59% (95% CI 7-82%) less susceptible than individuals 65 years and over. A transmission model calibrated against these data indicates that social distancing alone, as implemented in China during the outbreak, is sufficient to control COVID-19. While proactive school closures cannot interrupt transmission on their own, they reduce peak incidence by half and delay the epidemic. These findings can help guide global intervention policies.Competing Interest StatementA.V. has received funding from Metabiota Inc. H.Y. has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, and Shanghai Roche Pharmaceutical Company. This article does not necessarily represent the views of the NIH or the US government.Funding StatementH.Y. acknowledges financial support from the National Science Fund for Distinguished Young Scholars (No. 81525023), Key Emergency Project of Shanghai Science and Technology Committee (No. 20411950100), National Science and Technology Major Project of China (No. 2018ZX10201001-010, No. 2018ZX10713001-007, No. 2017ZX10103009-005). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. S.M. and M.A. acknowledge financial support from the European Commission H2020 MOOD project.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the main text or the supplementary materials.